Stock RH7 RYMAN HEALTHCARE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Ryman Healthcare Limited Deutsche Boerse AG

Equities

RH7

NZRYME0001S4

Market Closed - Deutsche Boerse AG
Other stock markets
 12:50:49 2024-06-28 EDT 		5-day change 1st Jan Change
2.07 EUR +1.97% Intraday chart for Ryman Healthcare Limited -6.17% -37.29%
06-27 Ryman Healthcare Chooses PwC Auckland as External Auditor MT
05-27 Transcript : Ryman Healthcare Limited, 2024 Earnings Call, May 27, 2024

Evolution of the average Target Price on Ryman Healthcare Limited

Price target over the last 5 years

History of analyst recommendation changes

13b.Imq_IEbdgRq07Ie51INXmuQPTaFvC5BuLXj151XSF0M.Yw76VA6zx2L5g97Sotlj06A8B5EHOuECQiGnnzC1bSdGIc1REPCzSMyg8A~cb4e8937e9f8ac582730e383d4d71cc1

Analyst Recommendations on Ryman Healthcare Limited

Jarden Upgrades Ryman Healthcare to Neutral from Underweight, Price Target is NZ$4.36 MT
UBS Adjusts Ryman Healthcare's Price Target to NZ$10.9 From NZ$10.5, Keeps at Neutral MT
New Zealand shares flat ahead of Fed rate meeting, Australia closed RE
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
3.56 NZD
Average target price
6.008 NZD
Spread / Average Target
+68.76%
High Price Target
7.25 NZD
Spread / Highest target
+103.65%
Low Price Target
4.04 NZD
Spread / Lowest Target
+13.48%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Ryman Healthcare Limited

Jarden Research
UBS

Ratings for Ryman Healthcare Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. RYM Stock
  4. RH7 Stock
  5. Consensus Ryman Healthcare Limited